← Back to screener

ABBOTT LABORATORIES ABT

Rank #966 · NYSE · $185.0B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
55.3
P/E
32.3
P/B
3.88
ROE
12.0%
Op. Margin
16.2%
Debt Ratio
71%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Average

P/E 32.3x, P/B 3.88x. Ranks in the top 51% of the universe.

Profitability ★★★☆☆
Good

ROE 12.0%. Ranks in the top 33% of the universe.

Safety ★★★★☆
Good

Debt ratio 71%. Ranks in the top 30% of the universe.

Growth ★☆☆☆☆
Poor

Revenue decline of 8.1% year over year. Ranks in the top 81% of the universe.

Safety is the relative strength · Growth is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$6.2B–$23.1B–127
2012–$6.1B–$22.7B–167
2013–$1.6B$4.7B$26.7B–126
2014–$1.4B$6.0B$25.2B–167
2015–$2.1B$2.6B$21.5B–99
2016–$2.6B$2.3B$21.2B–94
2017–$2.9B$4.4B$20.5B–101
2018$20.9B$3.0B$1.4B$30.9B14.570
2019$27.4B$1.6B$0.5B$30.5B5.7150
2020$30.6B$3.6B$2.4B$31.1B11.9116
2021$31.9B$4.5B$3.7B$32.8B14.2121
2022$34.6B$5.4B$4.5B$35.8B15.5110
2023$43.1B$8.4B$7.1B$36.7B19.6103
2024$43.7B$8.4B$6.9B$38.6B19.290
2025$40.1B$6.5B$5.7B$47.7B16.271

← See the full screener